<DOC>
	<DOCNO>NCT01529216</DOCNO>
	<brief_summary>The study purpose demonstrate benefit simplify version DIAMOND System ( A third Generation ) comparison sham treatment term Glycemic control , measure A1c , FBG Post-Prandial Glucose level . The study hypothesis HbA1c show great improvement patient receive 12 month therapy DIAMOMD System patient receive therapy .</brief_summary>
	<brief_title>Efficacy Study DIAMOND System Treat Type 2 Diabetes Mellitus</brief_title>
	<detailed_description>The study protocol also apply measure well understand mechanism action effect .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Male female subject 21 70 year age Body mass index ≥28 ≤ 45 ( kg/m2 ) Type 2 diabetes duration 6 month le 10 year . A baseline measurement ( visit BL1 ) HbA1c ≥ 7.5 % ≤ 10.5 % , Type 2 diabetic subject treat least 3 month one maximum tolerable dosage antidiabetic agent ( Any following : Sulfonylurea , Metformin , thiazolinedione ( TZD ) , DPP4 inhibitor ) . Stable antihypertensive lipidlowering medication least one month prior enrollment , take Women childbearing potential ( i.e. , postmenopausal surgically sterilize ) must agree use adequate birth control method Ability willingness perform require study data collection procedure adhere operate requirement System Alert , mentally competent , able understand willing comply requirement clinical trial , personally motivate abide requirement restriction clinical trial Able provide voluntary inform consent Injectable antidiabetic therapy within last 3 month ( insulin and/or GLP1 receptor agonist ) Taking medication know affect gastric motility narcotic ( chronic use ) anticholinergics/antispasmodics Any gastric upper GI surgery Experiencing severe progress diabetic complication ( i.e . retinopathy stabilize , nephropathy macroalbuminuria ) Prior wound heal problem Diagnosed past current psychiatric condition may impair ability comply study procedure Use antipsychotic medication Diagnosed eat disorder bulimia binge eat Obesity due endocrinopathy ( e.g . Cushing disease , Hypothyroidism treat ) Hiatal hernia require surgical repair paraesophageal hernia Pregnant lactating Diagnosed impaired liver function ( liver enzymes 3 time great normal ) Any prior bariatric surgery Any history pancreatitis Any history peptic ulcer disease within 10 year enrollment Diagnosed Gastroparesis GI motility disorder Use active medical device ( either implantable external ) ICD , pacemaker , drug infusion device , neurostimulator ( either implant worn ) . Subjects use external active device able willing avoid use device study may enrol . Cardiac history physician /surgeon feel exclude subject study . Use another investigational device agent 30 day prior enrollment A history lifethreatening disease within 5 year enrollment Any additional condition ( ) Investigator‟s opinion would warrant exclusion study prevent subject completing study</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>DIAMOND System</keyword>
	<keyword>T2DM</keyword>
	<keyword>Randomized study</keyword>
	<keyword>Electrical stimulation</keyword>
	<keyword>Fundus</keyword>
</DOC>